Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+61.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.70M | +43.6% |
| 2024 | $6.75M | +90.3% |
| 2023 | $3.55M | +53.8% |
| 2022 | $2.31M | - |